13F filer · CIK 1398346 ↗
Meitav Investment House Ltd
You are looking at Q3 2018. See the latest, Q3 2026 →
Reported value
$2.05B
−8.3% on the quarter before
Positions
441
60 new · 41 sold out
Top 10
28.5%
of the value
Est. gain
−$148.6M
on stocks held all quarter
Est. return
−8.5%
on those stocks since Q2 2018
Positions as of Sep 30, 2018, from Meitav Investment House Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2018. Striped tiles are options.
Largest buys
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Intl Equity Index F~$49.0MAdded · 1.7% → 3.7%+1,185,879 shares
- Solaredge Technologies Inc~$28.0MAdded · 2.1% → 3.0%+735,688 shares
- Invesco Exchange Traded Fd T~$23.9MNew · 0.0% → 1.2%+142,218 shares
- Kraneshares Tr~$22.0MNew · 0.0% → 1.1%+771,600 shares
- Mylan N V~$18.9MAdded · 2.8% → 3.9%+511,328 shares
- SPDR Series Trust~$15.9MAdded · 0.4% → 1.3%+160,190 shares
- Select Sector SPDR Tr~$11.4MNew · 0.0% → 0.6%+355,261 shares
- Select Sector SPDR Tr~$11.4MAdded · 2.5% → 3.0%+410,565 shares
- Universal Display Corp~$11.3MNew · 0.0% → 0.5%+96,300 shares
- Kraneshares Tr~$11.0MAdded · 1.2% → 1.6%+223,539 shares
Largest sells
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Gazit Globe Ltd~$52.0MCut · 3.2% → 0.2%−5,705,455 shares
- Rydex ETF Trust~$35.4MSold out · 1.6% → 0.0%−304,950 shares
- Israel Chemicals Ltd~$29.5MCut · 4.6% → 3.4%−4,790,175 shares
- Rydex ETF Trust~$28.1MSold out · 1.3% → 0.0%−240,354 shares
- Ishares Tr~$22.5MSold out · 1.0% → 0.0%−443,680 shares
- Ishares Tr~$21.3MCut · 1.8% → 0.7%−339,780 shares
- Ishares Inc~$19.9MSold out · 0.9% → 0.0%−276,711 shares
- Ishares Tr~$17.5MCut · 1.4% → 0.6%−404,146 shares
- Kornit Digital Ltd~$17.1MCut · 0.7% → 0.0%−793,332 shares
- Vaneck Vectors ETF Tr~$16.2MSold out · 0.7% → 0.0%−744,890 shares
Holdings
As of Sep 30, 2018. Changes are in shares against Jun 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan N VSHS EURO · shares +31% · price −2.3% | 3.9% | $79.2M | −$1.4M | ||||||||
| Vanguard Intl Equity Index FFTSE EMR MKT ETF · shares +177% · price −26.3% | 3.7% | $76.7M | −$9.9M | ||||||||
| Israel Chemicals LtdSHS · shares −30% · price −3.7% | 3.4% | $70.1M | −$2.7M | ||||||||
| Mellanox Technologies LtdSHS · shares +20% · price −17.6% | 3.0% | $62.4M | −$11.1M | ||||||||
| Select Sector SPDR TrSBI INT-FINL · shares +23% · price −9.8% | 3.0% | $62.1M | −$5.5M | ||||||||
| Solaredge Technologies IncCOM · shares +83% · price −28.8% | 3.0% | $61.8M | −$13.7M | ||||||||
| Ishares TrNA TEC SFTWR ETF · shares −15% · price +12.6% | 2.3% | $46.8M | +$5.3M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −20% · price +7.9% | 2.2% | $45.7M | +$3.3M | ||||||||
| Select Sector SPDR TrENERGY · shares −11% · price +1.3% | 2.0% | $41.9M | +$537,911 | ||||||||
| MicrosoftCOM · shares +4.5% · price +12.8% | 1.9% | $38.6M | +$4.2M | ||||||||
| Perrigo Co PlcSHS · shares +8.9% · price −45.9% | 1.8% | $37.7M | −$29.4M | ||||||||
| Amplify ETF TrONLIN RETL ETF · shares −25% · price +11.9% | 1.8% | $37.2M | +$4.0M | ||||||||
| Select Sector SPDR TrSBI CONS DISCR · shares +0.10% · price +9.4% | 1.8% | $36.3M | +$3.1M | ||||||||
| ETF Ser SolutionsUS GLB JETS · shares +0.05% · price +10.0% | 1.7% | $35.2M | +$3.2M | ||||||||
| Global X FdsRBTCS ARTFL INTE · shares −13% · price −0.5% | 1.6% | $33.6M | −$184,911 | ||||||||
| AmazonCOM · shares +30% · price +13.3% | 1.6% | $33.5M | +$3.0M | ||||||||
| Orbotech LtdORD · shares +4.7% · price −13.8% | 1.6% | $32.1M | −$4.9M | ||||||||
| Kraneshares TrCSI CHI INTERNET · shares +52% · price −20.0% | 1.6% | $32.1M | −$5.3M | ||||||||
| Vaneck Vectors ETF TrPHARMACEUTICAL · shares −0.2% · price +9.4% | 1.5% | $31.0M | +$2.7M | ||||||||
| CiscoCOM · shares +35% · price +10.6% | 1.5% | $30.0M | +$2.1M | ||||||||
| Ishares TrLATN AMER 40 ETF · shares +37% · price +2.9% | 1.4% | $29.1M | +$599,650 | ||||||||
| Urogen Pharma LtdCOM · shares +15% · price −19.1% | 1.4% | $27.8M | −$5.7M | ||||||||
| SPDR Series TrustAEROSPACE DEF · shares +153% · price +14.1% | 1.3% | $26.4M | +$1.3M | ||||||||
| PayPalCOM · shares +30% · price +9.2% | 1.3% | $26.0M | +$1.7M | ||||||||
| Select Sector SPDR TrSBI CONS STPLS · shares +25% · price +10.3% | 1.2% | $25.5M | +$1.9M | ||||||||
| Total · 441 positions | 100% | $2.05B | −$148.6M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2018 to Q3 2018: 381 stocks held throughout, down $148.6M (−8.5%).
- Ishares Tr+$5.3M+13%
- Microsoft+$4.2M+13%
- Amplify ETF Tr+$4.0M+12%
- Galmed Pharmaceuticals Ltd+$3.5M+118%
- Vanguard Index Fds+$3.3M+8%
- Nova Measuring Instruments L−$12.2M−70%
- Solaredge Technologies Inc−$13.7M−29%
- Ormat Technologies Inc−$15.7M−57%
- Elbit Sys Ltd−$21.5M−70%
- Perrigo Co Plc−$29.4M−46%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | $15.54B+5% | SEC ↗ |
| Q2 2026 | Jul 20, 2026 | $14.87B+63% | SEC ↗ |
| Q1 2026 | Apr 29, 2026 | $9.12B+5% | SEC ↗ |
| Q4 2025 | Feb 10, 2026 | $8.66B+14% | SEC ↗ |
| Q3 2025 | Oct 29, 2025 | $7.57B+2% | SEC ↗ |
| Q2 2025 | Jul 23, 2025 | $7.42B+37% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $5.43B−8% | SEC ↗ |
| Q4 2024 | Feb 3, 2025 | $5.93B−1% | SEC ↗ |
| Q3 2024 | Oct 28, 2024 | $5.97B+6% | SEC ↗ |
| Q2 2024 | Jul 29, 2024 | $5.62B+10% | SEC ↗ |
| Q1 2024 | May 1, 2024 | $5.10B−25% | SEC ↗ |
| Q4 2023 | Jan 29, 2024 | $6.81B+10% | SEC ↗ |
| Q3 2023 | Oct 30, 2023 | $6.17B−50% | SEC ↗ |
| Q2 2023 | Jul 24, 2023 (amended) | $12.45B+115% | SEC ↗ |
| Q1 2023 | May 11, 2023 | $5.79B−1% | SEC ↗ |
| Q4 2022 | Feb 6, 2023 | $5.82B+3% | SEC ↗ |
| Q3 2022 | Oct 31, 2022 | $5.67B−3% | SEC ↗ |
| Q2 2022 | Aug 1, 2022 | $5.86B−13% | SEC ↗ |
| Q1 2022 | May 9, 2022 | $6.74B+10% | SEC ↗ |
| Q4 2021 | Feb 8, 2022 | $6.14B+1% | SEC ↗ |
| Q3 2021 | Nov 3, 2021 | $6.10B−22% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 (amended) | $7.81B+119% | SEC ↗ |
| Q1 2021 | May 6, 2021 | $3.57B+40% | SEC ↗ |
| Q4 2020 | Feb 2, 2021 | $2.55B+27% | SEC ↗ |
| Q3 2020 | Nov 5, 2020 | $2.02B+21% | SEC ↗ |
| Q2 2020 | Aug 10, 2020 | $1.67B+25% | SEC ↗ |
| Q1 2020 | May 11, 2020 | $1.34B−3% | SEC ↗ |
| Q4 2019 | Feb 10, 2020 | $1.38B−1% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $1.39B−7% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.50B−16% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $1.78B+10% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $1.62B−21% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.05B−8% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.24B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.97B+15% | SEC ↗ |
| Q4 2017 | Feb 15, 2018 | $1.71B | SEC ↗ |